Title/Subject: More than $180 million in funding committed to preventing heart attacks and strokes
Million Hearts® is pleased to share information on innovative programs that were recently funded to help prevent heart attacks and strokes.
The three programs, all announced in May 2015, represent $180 million committed to cardiovascular disease prevention, impacting almost 8.5 million people at risk for heart attack and stroke.
Apply Today! Centers for Medicare and Medicaid Services: Million Hearts® Cardiovascular Disease Risk Reduction Model
The Centers for Medicare and Medicaid Services (CMS) announced the Million Hearts® Cardiovascular Disease Risk Reduction Model, aimed at preventing heart attacks and strokes in high risk Medicare beneficiaries. CMS is currently accepting applications for the model, which will launch in January 2016 and will operate for five years.
The Risk Reduction model will use an innovative approach to lowering risk of cardiovascular disease, incentivizing risk assessment and prevention. Currently, providers are paid to meet specific blood pressure, cholesterol, and other targets in Medicare patients; in contrast the Risk Reduction model pays providers when they see reductions in the absolute risk for heart disease or stroke. Using a data-driven, widely accepted predictive modeling technique, the model allows providers to generate individual cardiovascular disease risk scores for Medicare patients. The patients and clinicians work together to identify the best way to reduce the patient’s risk for heart attack or stroke, such as stopping smoking or getting blood pressure under control. Patients receive a personalized risk modification plan.
The model aims to enroll 720 practices across the United States so as to reach over 300,000 Medicare beneficiaries. This is an unprecedented opportunity to concentrate on lowering a population’s risk of having a heart attack and stroke. Please disseminate this call for applications widely.
For more information on how to apply and on the Million Hearts® Cardiovascular Disease Risk Reduction Initiative, visithttp://innovation.cms.gov/
Agency for Healthcare Research and Quality (AHRQ): EvidenceNOW: Advancing Heart Health in Primary Care
AHRQ announced awards to seven grantees to ensure that primary care practices have information on evidence-based practices and use that information to improve their patients’ heart health. The grantees will work with about 5,000 primary care professionals in smaller practices across 12 states, reaching nearly 8 million patients.
EvidenceNOW establishes seven regional cooperatives composed of multidisciplinary teams of experts who will provide onsite coaching, consultation on healthcare delivery improvement, information on best practices, and/or electronic health record support. The initiative will help up to 300 small and medium-sized primary care practices incorporate the most recent evidence on how best to deliver the Million Hearts ABCS of cardiovascular prevention—Aspirin use by high risk individuals, Blood pressure control, Cholesterol management, and Smoking cessation.
For more information and a list of grantees, visit http://www.ahrq.gov/
Patient-Centered Outcomes Research Institute: Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
Patient-Centered Outcomes Research Institute (PCORI) has recently announced that Duke University has received $14 million for a three-year randomized controlled trial to determine whether low- or standard-dose aspirin is better for preventing heart attacks and strokes in patients with coronary artery disease. The trial is known as ADAPTABLE.
ADAPTABLE will help determine the optimal dose of aspirin to maximize cardiovascular protection while minimizing bleeding. The study is scheduled to launch in fall 2015 and aims to enroll 20,000 patients who are at high risk for heart attack or stroke.
For more information on ADAPTABLE, visit http://www.pcornet.org/2015/
For more information on Million Hearts, go to http://millionhearts.hhs.gov.
No hay comentarios:
Publicar un comentario